MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+7.25%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.5B
AUM Growth
+$70.3M
(+4.9%)
Cap. Flow
+$8.44M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
42.83%
Holding
998
New
140
Increased
340
Reduced
262
Closed
157
Top Buys
| 1 |
Simon Property Group
SPG
|
+$27.7M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$23.7M |
| 3 |
Medtronic
MDT
|
+$15.1M |
| 4 |
Waste Management
WM
|
+$14.1M |
| 5 |
Netflix
NFLX
|
+$13.8M |
Top Sells
| 1 |
Analog Devices
ADI
|
+$27M |
| 2 |
Microsoft
MSFT
|
+$24.6M |
| 3 |
Elevance Health
ELV
|
+$22.2M |
| 4 |
Merck
MRK
|
+$21.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$17.9M |
Sector Composition
| 1 | Technology | 27.32% |
| 2 | Financials | 16.31% |
| 3 | Healthcare | 13.63% |
| 4 | Consumer Discretionary | 12.77% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Werner Enterprises
WERN
$1.71B
| $4.75K | ﹤0.01% |
+123
| New | +$4.75K |
|
752
Hubbell
HUBB
$23.2B
| $4.71K | ﹤0.01% |
11
-26
| -70% | -$11.1K |
|
753
Cabot Corp
CBT
$4.31B
| $4.69K | ﹤0.01% |
+42
| New | +$4.69K |
|
754
Penumbra
PEN
$11.1B
| $4.66K | ﹤0.01% |
24
+3
| +14% | +$583 |
|
755
Denali Therapeutics
DNLI
$2.27B
| $4.63K | ﹤0.01% |
+159
| New | +$4.63K |
|
756
Revolution Medicines
RVMD
$7.68B
| $4.63K | ﹤0.01% |
102
+30
| +42% | +$1.36K |
|
757
Neurocrine Biosciences
NBIX
$14.3B
| $4.61K | ﹤0.01% |
40
-8
| -17% | -$922 |
|
758
Curtiss-Wright
CW
$18.2B
| $4.6K | ﹤0.01% |
14
-47
| -77% | -$15.5K |
|
759
SS&C Technologies
SSNC
$21.7B
| $4.6K | ﹤0.01% |
+62
| New | +$4.6K |
|
760
Pentair
PNR
$18.1B
| $4.6K | ﹤0.01% |
47
-133
| -74% | -$13K |
|
761
Lumen
LUMN
$5.25B
| $4.59K | ﹤0.01% |
+647
| New | +$4.59K |
|
762
Cleveland-Cliffs
CLF
$5.45B
| $4.52K | ﹤0.01% |
354
+31
| +10% | +$396 |
|
763
Watsco
WSO
$16.6B
| $4.43K | ﹤0.01% |
9
-17
| -65% | -$8.36K |
|
764
Owens Corning
OC
$13B
| $4.41K | ﹤0.01% |
25
-21,623
| -100% | -$3.82M |
|
765
Fortune Brands Innovations
FBIN
$7.29B
| $4.39K | ﹤0.01% |
49
-141
| -74% | -$12.6K |
|
766
Exact Sciences
EXAS
$10.2B
| $4.36K | ﹤0.01% |
64
-16
| -20% | -$1.09K |
|
767
Repligen
RGEN
$6.79B
| $4.32K | ﹤0.01% |
29
-6
| -17% | -$893 |
|
768
Rhythm Pharmaceuticals
RYTM
$6.63B
| $4.3K | ﹤0.01% |
+82
| New | +$4.3K |
|
769
Atea Pharmaceuticals
AVIR
$258M
| $4.29K | ﹤0.01% |
+1,281
| New | +$4.29K |
|
|
BPMC
770
DELISTED
Blueprint Medicines
BPMC
| $4.26K | ﹤0.01% |
46
+16
| +53% | +$1.48K |
|
771
SL Green Realty
SLG
$4.32B
| $4.25K | ﹤0.01% |
61
+8
| +15% | +$557 |
|
772
Kellanova
K
$27.6B
| $4.2K | ﹤0.01% |
+52
| New | +$4.2K |
|
773
TransUnion
TRU
$18.2B
| $4.08K | ﹤0.01% |
39
-106
| -73% | -$11.1K |
|
774
Booz Allen Hamilton
BAH
$12.5B
| $4.07K | ﹤0.01% |
25
-65
| -72% | -$10.6K |
|
775
Insmed
INSM
$31B
| $4.02K | ﹤0.01% |
55
+8
| +17% | +$584 |
|